Do you want to read an article? Please log in or register.
Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry.
Cardiac Arrest or Death
Related content
Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
JAMA Cardiol.
Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM
doi: 10.1001/
Cardiac Arrest or DeathHeart, Artery and Coronary DiseasesHeart Failure
Age and Outcomes of Primary Prevention Implantable Cardioverter Defibrillators in Patients with Non-Ischemic Systolic Heart Failure
Circulation.
Elming MB, Nielsen JC, Haarbo J, Videbæk L, Korup E, Signorovitch J, Olesen LL, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Køber L, Thune JJ
doi: 10.1161/
Heart Failure
Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure
JAMA Cardiol.
Fudim M, Ali-Ahmed F, Parzynski CS, Ambrosy AP, Friedman DJ, Pokorney SD, Curtis JP, Fonarow GC, Masoudi FA, Hernandez AF, Al-Khatib SM
doi: 10.1001/jamacardio.2020.0391.
COMMENTED
Cardiac Arrest or Death
Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry
★ 3
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
doi: 10.1007/s00392-019-01584-x.
Heart Failure
Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure
Eur J Heart Fail.
Echouffo-Tcheugui JB, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC
doi: 10.1002/ejhf.1552.
Cardiac Arrest or DeathHeart, Artery and Coronary Diseases
Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry
Clin Res Cardiol.
Frommeyer G, Reinke F, Andresen D, Kleemann T, Spitzer SG, Jehle J, Brachmann J, Stellbrink C, Hochadel M, Senges J, Eckardt L
doi: 10.1007/s00392-019-01532-9.
Heart FailureThrombosis and Stroke
Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry
JACC Heart Fail.
Clerkin KJ, Topkara VK, Demmer RT, Dizon JM, Yuzefpolskaya M, Fried JA, Mai X, Mancini DM, Takeda K, Takayama H, Naka Y, Colombo PC, Garan AR
doi: 10.1016/j.jchf.2017.08.014.
Cardiac Arrest or Death
Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry
J Am Heart Assoc.
Poli S, Boriani G, Zecchin M, Facchin D, Gasparini M, Landolina M, Ricci RP, Lanera C, Gregori D, Proclemer A
doi: 10.1161/JAHA.119.012759.
Cardiac Arrest or DeathHeart, Artery and Coronary Diseases
Primary Prevention Implantable Cardioverter Defibillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis
JAMA Cardiol.
Al-Khatib SM, Fonarow GC, Joglar JA, Inoue LY, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD
doi: 10.1001/jamacardio.